Fragile X Syndrome

Chevreul, K., Gandré, C., Brigham, K. B., López-Bastida, J., Linertová, R., Oliva-Moreno, J., … BURQOL-RD Research Network (2016). Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe. The European journal of health economics : HEPAC : health economics in prevention and care, 17 Suppl 1, 43–52. doi:10.1007/s10198-016-0784-3

Raspa, M., Sacco, P., Candrilli, S. D., Bishop, E., & Petrillo, J. (2016). Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index. Journal of intellectual disability research : JIDR, 60(9), 844–855. doi:10.1111/jir.12264

Tara Nazareth, Nanxin Li, Maryna Marynchenko, Zhou Zhou, Pooja Chopra, James Signorovitch, Eric Wu, Saeed Ahmed, Jessica Marvel & Rahul Sasane (2016) Burden of illness among patients with fragile X syndrome (FXS): a Medicaid perspective, Current Medical Research and Opinion, 32:3, 405-416,

Vekeman, F., Gauthier-Loiselle, M., Faust, E., Lefebvre, P., Lahoz, R., Duh, M. S., & Sacco, P. (2015). Patient and Caregiver Burden Associated With Fragile X Syndrome in the United States. American journal on intellectual and developmental disabilities, 120(5), 444–459. doi:10.1352/1944-7558-120.5.444

Angelis, A., Tordrup, D., & Kanavos, P. (2015). Socio-economic burden of rare diseases: A systematic review of cost of illness evidence. Health policy (Amsterdam, Netherlands), 119(7), 964–979. doi:10.1016/j.healthpol.2014.12.016

Eckert, E. M., Dominick, K. C., Pedapati, E. V., Wink, L. K., Shaffer, R. C., Andrews, H., … Erickson, C. A. (2019). Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis. Journal of autism and developmental disorders, 49(11), 4595–4602. doi:10.1007/s10803-019-04173-z